[Clinical Characteristics and Survival Analysis of Patients with Chronic Myelomonocytic Leukemia].

Wang, Jing-Yu; Chen, Jian-Fang; Wang, Shi-Fang; Guo, Qiao-Hua; Ma, Yan-Ping

Wang, Jing-Yu; Chen, Jian-Fang; Wang, Shi-Fang; Guo, Qiao-Hua; Ma, Yan-Ping.

Afiliación

Wang JY; The Second Clinical Medical College of Shanxi Medical University; Taiyuan 030000, Shanxi Province, China.
Chen JF; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030000, Shanxi Province, China.
Wang SF; The Second Clinical Medical College of Shanxi Medical University; Taiyuan 030000, Shanxi Province, China.
Guo QH; The Second Clinical Medical College of Shanxi Medical University; Taiyuan 030000, Shanxi Province, China.
Ma YP; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030000, Shanxi Province, China.E-mail: myanp18@163.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 31(2): 476-482, 2023 Apr.

Article en Zh | MEDLINE | ID: mdl-37096522

Asunto(s)

Leucemia Mielomonocítica Crónica; Humanos; Anciano; Leucemia Mielomonocítica Crónica/genética; Estudios Retrospectivos; Hibridación Fluorescente in Situ; Análisis de Supervivencia; Pronóstico

Palabras clave

chronic myelomonocytic leukemia; efficacy; gene mutation; hypomethylating agent; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielomonocítica Crónica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google